Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-02-13
1999-12-28
Pak, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514373, 514499, 514500, 514970, 514971, 514973, 424630, 424632, 424633, 424634, 424635, 424637, 424638, 424661, 424662, 424667, 424668, 504151, 504156, A01N 4380, A01N 5920, A01N 5502, A01N 2522
Patent
active
060082380
ABSTRACT:
Disclosed is a stable dilute solution composition of a 3-isothiazolone compound selected from the group consisting of 5-chloro-2-methyl-3-isothiazolone, 2-methyl-3-isothiazolone, 5-chloro-2-ethyl-3-isothiazolone, 2-ethyl-3-isothiazolone, 4,5-dichloro-2-methyl-3-isothiazolone, and mixtures thereof in water having extremely low levels of copper ion and an oxidant.
REFERENCES:
patent: 3870795 (1975-03-01), Miller et al.
patent: 5153213 (1992-10-01), Schmidt
patent: 5461150 (1995-10-01), Gironda et al.
patent: 5869510 (1999-02-01), Mattox
patent: 5910503 (1999-06-01), Mattox et al.
patent: 5922745 (1999-07-01), McCarthy et al.
El A'mma Beverly Jean
Mattox John Robert
Cairns S. Mathew
Pak John
Rohm and Haas Company
LandOfFree
Stabilization of 3-isothiazolone solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilization of 3-isothiazolone solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilization of 3-isothiazolone solutions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2382712